Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro

Ovarian cancer is the second leading cause of death of female gynecological malignant tumor patients worldwide. Although surgery and chemotherapy have achieved dramatic achievement, the mortality remains high, resulting in the demand for new specific drug discovery. Disrupting ovarian cancer growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Lulu, Lai, Tianjiao, Zhao, Junru, Jin, Yuxi, Qi, Meng, Li, Mingyue, Fu, Hanlin, Shi, Xiaojing, Ma, Liying, Guo, Ruixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715740/
https://www.ncbi.nlm.nih.gov/pubmed/36467091
http://dx.doi.org/10.3389/fphar.2022.1064485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715740/
https://www.ncbi.nlm.nih.gov/pubmed/36467091
http://dx.doi.org/10.3389/fphar.2022.1064485

Ejemplares similares